Perirenal Fat Thickness Significantly Associated with Prognosis of Metastatic Renal Cell Cancer Patients Receiving Anti-VEGF Therapy

Perirenal Fat Thickness Significantly Associated with Prognosis of Metastatic Renal Cell Cancer Patients Receiving Anti-VEGF Therapy

Although high body mass index (BMI) was reported to associate with a better prognosis for metastatic renal cell cancer (mRCC) patients receiving anti-vascular endothelial growth factor (anti-VEGF) therapy, it is an imperfect proxy for the body composition, especially in Asian patients with a lower B...

Full description

Bibliographic Details
Main Authors: Kang Ning, Zhen Li, Huiming Liu, Xi Tian, Jun Wang, Yi Wu, Longbin Xiong, Xiangpeng Zou, Yulu Peng, Zhaohui Zhou, Fangjian Zhou, Chunping Yu, Junhang Luo, Hailiang Zhang, Pei Dong, Zhiling Zhang
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Nutrients
Subjects:
body composition
adipose tissue
renal cell carcinoma
prognosis
anti-VEGF therapy
Online Access:https://www.mdpi.com/2072-6643/14/16/3388

Internet

https://www.mdpi.com/2072-6643/14/16/3388

Similar Items